Weekly reads: Prasad successor, Sammy Hagar stem cells, more on OSK trial, Finnish speaker needed
Professor Paul Knoepfler, Ph.D.
Vinay Prasad has only less than two weeks left at the FDA atop CBER. I’ve been trying to imagine where CBER goes from here after he exits. It feels like FDA Commissioner Marty Makary and RFK Jr. will likely be the real leaders of CBER moving forward on key decisions. Under that pressure, will the […] The post Weekly reads: Prasad successor, Sammy Hagar stem cells, more on OSK trial, Finnish speaker needed appeared first on The Niche .